Literature DB >> 33064144

Postlicensure Evaluation of COVID-19 Vaccines.

Manish M Patel1, Michael L Jackson2, Jill Ferdinands1.   

Abstract

Entities:  

Year:  2020        PMID： 33064144     DOI： 10.1001/jama.2020.19328

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Durability analysis of the highly effective BNT162b2 vaccine against COVID-19.

Authors:  Arjun Puranik; Patrick J Lenehan; John C O'Horo; Colin Pawlowski; Michiel J M Niesen; Abinash Virk; Melanie D Swift; Walter Kremers; A J Venkatakrishnan; Joel E Gordon; Holly L Geyer; Leigh Lewis Speicher; Venky Soundararajan; Andrew D Badley
Journal:  PNAS Nexus       Date:  2022-06-08

2.  Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: Population-based cohort study.

Authors:  Mina Tadrous; Hannah Chung; Siyu Men; Cherry Chu; Tonya Campbell; David N Juurlink; Jeffrey C Kwong; J Michael Paterson; Tara Gomes
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

3.  Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.

Authors:  Samantha M Olson; Margaret M Newhams; Natasha B Halasa; Ashley M Price; Julie A Boom; Leila C Sahni; Pia S Pannaraj; Katherine Irby; Tracie C Walker; Stephanie P Schwartz; Aline B Maddux; Elizabeth H Mack; Tamara T Bradford; Jennifer E Schuster; Ryan A Nofziger; Melissa A Cameron; Kathleen Chiotos; Melissa L Cullimore; Shira J Gertz; Emily R Levy; Michele Kong; Natalie Z Cvijanovich; Mary A Staat; Satoshi Kamidani; Brandon M Chatani; Samina S Bhumbra; Katherine E Bline; Mary G Gaspers; Charlotte V Hobbs; Sabrina M Heidemann; Mia Maamari; Heidi R Flori; Janet R Hume; Matt S Zinter; Kelly N Michelson; Laura D Zambrano; Angela P Campbell; Manish M Patel; Adrienne G Randolph
Journal:  N Engl J Med       Date:  2022-01-12       Impact factor: 176.079

4.  Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).

Authors:  Mark A Katz; Efrat Bron Harlev; Bibiana Chazan; Michal Chowers; David Greenberg; Alon Peretz; Sagi Tshori; Joseph Levy; Mili Yacobi; Avital Hirsch; Doron Amichay; Ronit Weinberger; Anat Ben Dor; Elena Keren Taraday; Dana Reznik; Chen Barazani Chayat; Dana Sagas; Haim Ben Zvi; Rita Berdinstein; Gloria Rashid; Yonat Shemer Avni; Michal Mandelboim; Neta Zuckerman; Nir Rainy; Amichay Akriv; Noa Dagan; Eldad Kepten; Noam Barda; Ran D Balicer
Journal:  Vaccine       Date:  2021-12-10       Impact factor: 3.641

5.  Impact of prior vaccination with CovishieldTM and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study.

Authors:  Kundavaram Paul Prabhakar Abhilash; Ponnivalavan Mathiyalagan; Vivek Raja K Krishnaraj; Saravanan Selvan; Rohini Kanagarajan; Narmadha P Reddy; Natarajan Rajendiran; Darpanarayan Hazra; Karthik Gunasekaran; Mahesh Moorthy; Sudha Jasmine; John Prasad Davis; Tina George; Krupa George; George M Varghese; Priscilla Rupali; T J Barney Isaac; Richa Gupta; Kishore Pichamuthu; Melvin Joy; Lakshmanan Jayaseelan; Prasad Mathews; John Victor Peter
Journal:  Vaccine       Date:  2022-02-10       Impact factor: 4.169

6.  Estimands and Estimation of COVID-19 Vaccine Effectiveness Under the Test-Negative Design: Connections to Causal Inference.

Authors:  Mireille E Schnitzer
Journal:  Epidemiology       Date:  2022-05-01       Impact factor: 4.822

7.  Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness.

Authors:  Kendrick Qijun Li; Xu Shi; Wang Miao; Eric Tchetgen Tchetgen
Journal:  ArXiv       Date:  2022-03-23

8.  Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.

Authors:  Ariel Israel; Eugene Merzon; Alejandro A Schäffer; Yotam Shenhar; Ilan Green; Avivit Golan-Cohen; Eytan Ruppin; Eli Magen; Shlomo Vinker
Journal:  BMJ       Date:  2021-11-24

9.  Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California.

Authors:  Kristin L Andrejko; Jake Pry; Jennifer F Myers; Nicholas P Jewell; John Openshaw; James Watt; Seema Jain; Joseph A Lewnard
Journal:  Clin Infect Dis       Date:  2022-04-28       Impact factor: 20.999

10.  COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data.

Authors:  Shela Sridhar; Albana Fico; Iria Preza; Iris Hatibi; Jonilda Sulo; Esther Kissling; Rovena Daja; Rawi Ibrahim; Diogo Lemos; Julia Rubin-Smith; Alexis Schmid; Adela Vasili; Marta Valenciano; Pernille Jorgensen; Richard Pebody; Kathryn E Lafond; Mark A Katz; Silvia Bino
Journal:  BMJ Open       Date:  2022-03-23       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.